Difference between revisions of "Template:COVID-19 Testing, Reporting, and Information Management in the Laboratory/Final thoughts and additional resources/Key journal articles"

From LIMSWiki
Jump to navigationJump to search
(Updated for August)
Line 1: Line 1:
===4.4 Key journal articles===
===5.4 Key journal articles===


* {{cite journal |title=Testing Individuals for Coronavirus Disease 2019 (COVID-19) |journal=JAMA |author=Hadaya, J.; Schumm, M.; Livingston, E.H. |year=2020 |doi=10.1001/jama.2020.5388 |pmid=32236503}}
* {{cite journal |title=Testing Individuals for Coronavirus Disease 2019 (COVID-19) |journal=JAMA |author=Hadaya, J.; Schumm, M.; Livingston, E.H. |year=2020 |doi=10.1001/jama.2020.5388 |pmid=32236503}}
Line 8: Line 8:


* {{cite journal |title=Diagnosing COVID-19: The Disease and Tools for Detection |journal=ACS Nano |author=Udugama, B.; Kadhiresan, P.; Kozlowski, H.N. et al. |volume=14 |issue=4 |pages=3822–3835 |year=2020 |doi=10.1021/acsnano.0c02624 |pmid=32223179 |pmc=PMC7144809}}
* {{cite journal |title=Diagnosing COVID-19: The Disease and Tools for Detection |journal=ACS Nano |author=Udugama, B.; Kadhiresan, P.; Kozlowski, H.N. et al. |volume=14 |issue=4 |pages=3822–3835 |year=2020 |doi=10.1021/acsnano.0c02624 |pmid=32223179 |pmc=PMC7144809}}
* {{cite journal |title=Laboratory information system requirements to manage the COVID-19 pandemic: A report from the Belgian national reference testing center |journal=JAMIA |author=Weemaes, M.; Martens, S.; Cuypers, L. et al. |at=ocaa081 |year=2020 |doi=10.1093/jamia/ocaa081 |pmid=32348469 |pmc=PMC7197526}}


* {{cite journal |title=COVID-19 Testing: The Threat of False-Negative Results |journal=Mayo Clinic Proceedings |author=West, C.P.; Montori, V.M.; Sampathkumar, P. |volume=95 |issue=6 |pages=1127–29 |year=2020 |doi=10.1016/j.mayocp.2020.04.004 |pmid=32376102 |pmc=PMC7151274}}
* {{cite journal |title=COVID-19 Testing: The Threat of False-Negative Results |journal=Mayo Clinic Proceedings |author=West, C.P.; Montori, V.M.; Sampathkumar, P. |volume=95 |issue=6 |pages=1127–29 |year=2020 |doi=10.1016/j.mayocp.2020.04.004 |pmid=32376102 |pmc=PMC7151274}}


* {{cite journal |title=SARS-CoV-2 and COVID-19: The most important research questions |journal=Cell & Bioscience |author=Yuen, K.-S.; Fung, S.-Y.; Chan, C.-P.; Jin, D.-Y. |volume=10 |at=40 |year=2020 |doi=10.1186/s13578-020-00404-4 |pmid=32190290 |pmc=PMC7074995}}
* {{cite journal |title=SARS-CoV-2 and COVID-19: The most important research questions |journal=Cell & Bioscience |author=Yuen, K.-S.; Fung, S.-Y.; Chan, C.-P.; Jin, D.-Y. |volume=10 |at=40 |year=2020 |doi=10.1186/s13578-020-00404-4 |pmid=32190290 |pmc=PMC7074995}}

Revision as of 18:59, 23 August 2020

5.4 Key journal articles


  • Iwen, P.C.; Stiles, K.L.; Pantella, M.A. (2020). "Safety considerations in the laboratory testing of specimens suspected or known to contain the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)". American Journal of Clinical Pathology: aqaa047. doi:10.1093/ajcp/aqaa047. PMID 32190890. 


  • Loeffelholz, M.J.; Tang, T.-W. (2020). "Laboratory diagnosis of emerging human coronavirus infections – The state of the art". Emerging Microbes & Infections 9 (1): 747–56. doi:10.1080/22221751.2020.1745095. PMID 32196430.